Item 4. CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of management, including

our principal executive officer and

principal financial officer, we evaluated the effectiveness of the design and operation of our disclosure controls and

procedures as of the end of the period covered by this quarterly report

as such term is defined in Rules 13a-15(e)

and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as

amended (the “Exchange Act”).

Based

on this evaluation, our management, including our principal executive officer and principal

financial officer,

concluded that our disclosure controls and procedures were effective as of September 24,

2022, to ensure that all

material information required to be disclosed by us in reports that we file

or submit under the Exchange Act is

accumulated and communicated to them as appropriate to allow timely

decisions regarding required disclosure and

that all such information is recorded, processed, summarized and reported

within the time periods specified in the

SEC’s rules and forms.

Changes in Internal Control over Financial Reporting

The combination of acquisitions, continued acquisition integrations and systems

implementation activity

undertaken during the quarter and carried over from prior quarters when considered

in the aggregate, represents a

material change in our internal control over financial reporting.

During the quarter ended September 24, 2022, we completed the acquisition

of dental businesses in North America

and Europe.

Also, post-acquisition integration related activities continued

for our dental and medical businesses

acquired during prior quarters.

These acquisitions, the majority of which utilize separate

information and financial

accounting systems, have been included in our condensed consolidated

financial statements since their respective

dates of acquisition.

In addition, we completed systems implementation activities

in North America related to a

new ERP system for a dental business as well as the integration of a

dental business onto an existing ERP system.

All acquisitions, continued acquisition integrations and systems implementation

activity involve necessary and

appropriate change-management controls that are considered in our quarterly

assessment of the design and

operating effectiveness of our internal control over financial reporting.

Limitations of the Effectiveness of Internal Control

A control system, no matter how well conceived and operated, can provide

only reasonable, not absolute, assurance

that the objectives of the internal control system are met.

Because of the inherent limitations of any internal control

system, no evaluation of controls can provide absolute assurance that

all control issues, if any, within a company

have been detected.

PART

II.

OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

For a discussion of Legal Proceedings, see

Note 9–Legal Proceedings

of the Notes to the Condensed Consolidated

Financial Statements included under Item 1.